Research Article
Prospective Study of BK Virus Infection in Patients with Inflammatory Bowel Disease
Table 2
Comparison of inflammatory bowel disease patients with and without BKV viruria.
| | | All patients | Viruric patients | Nonviruric patients | value | | | | | |
| | Age (mean ± SD) | | | | 0.036 | | Males (%) | 26 (49.1) | 12 (46.2) | 14 (53.8) | 0.217 | | Type of IBD | | | | | | Crohn’s disease (%) | 32 (60.4) | 17 (53.1) | 15 (46.9) | 0.610 | | Ulcerative colitis (%) | 21 (39.6) | 12 (57.1) | 9 (42.9) | | Previous surgery (%) | 18 (34.0) | 8 (44.4) | 10 (55.6) | 0.930 | | Severity of IBD | | | | | | Severe | 7 (13.2) | 4 (57.1) | 3 (42.9) | 0.890 | | Nonsevere | 46 (86.8) | 25 (54.3) | 21 (45.7) | | Hospital admission at inclusion (%) | | | | | | No | 39 (73.6) | 24 (61.5) | 15 (38.5) | 0.096 | | Yes | 14 (26.4) | 5 (35.7) | 9 (64.3) | | Immunosuppressive therapy (%) | | | | | | No | 12 (22.6) | 5 (41.7) | 7 (58.3) | 0.302 | | Yes | 41 (77.4) | 24 (58.5) | 17 (41.5) | | Infliximab/adalimumab | | | | | | No | 29 (54.7) | 15 (51.7) | 14 (48.3) | 0.630 | | Yes | 24 (45.3) | 14 (58.3) | 10 (41.7) | | Systemic corticosteroids | | | | | | No | 45 (84.9) | 23 (51.1) | 22 (48.9) | 0.771 | | Yes | 8 (15.1) | 6 (75) | 2 (25) | Serum creatinine
(mg/dL, mean ± SD) | | | | 0.411 | | Ciprofloxacin at inclusion | | | | | | No | 42 (79.2) | 25 (59.5) | 17 (40.5) | 0.170 | | Yes | 11 (20.8) | 4 (36.4) | 7 (63.6) | | Urinalysis | | | | | | Hematuria | 6 (11.3) | 4 (13.8) | 2 (8.3) | 0.532 | | Leukocyturia | 8 (15.1) | 5 (17.2) | 3 (12.5) | 0.631 |
|
|
Statistically significant values are shown in bold.
|
